Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Are UK cancer cure rates worse than in most other European countries?

Literature DB >> 20132700

Are UK cancer cure rates worse than in most other European countries?

Robert Souhami.

Abstract

Mesh：

Year: 2010 PMID： 20132700 PMCID： PMC2814259 DOI： 10.3399/bjgp10X483102

Source DB: PubMed Journal: Br J Gen Pract ISSN： 0960-1643 Impact factor: 5.386

× No keyword cloud information.

12 in total

1. Cancer survival statistics should be viewed with caution.

Authors: Philippe Autier; Mathieu Boniol; Clarisse Héry; Eric Masuyer; Jacques Ferlay
Journal: Lancet Oncol Date: 2007-12 Impact factor: 41.316

2. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study.

Authors: G Gatta; R Capocaccia; M Sant; C M Bell; J W Coebergh; R A Damhuis; J Faivre; C Martinez-Garcia; J Pawlega; M Ponz de Leon; D Pottier; N Raverdy; E M Williams; F Berrino
Journal: Gut Date: 2000-10 Impact factor: 23.059

3. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors: Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal: Eur J Cancer Date: 2009-01-24 Impact factor: 9.162

4. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.

Authors: Franco Berrino; Roberta De Angelis; Milena Sant; Stefano Rosso; Magdalena Bielska-Lasota; Magdalena B Lasota; Jan W Coebergh; Mariano Santaquilani
Journal: Lancet Oncol Date: 2007-09 Impact factor: 41.316

5. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe.

Authors: Milena Sant; Claudia Allemani; Riccardo Capocaccia; Timo Hakulinen; Tiiu Aareleid; Jan Willem Coebergh; Michel P Coleman; Pascale Grosclaude; Carmen Martinez; Janine Bell; Judith Youngson; Franco Berrino
Journal: Int J Cancer Date: 2003-09-01 Impact factor: 7.396

6. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Authors: Ruth Etzioni; David F Penson; Julie M Legler; Dante di Tommaso; Rob Boer; Peter H Gann; Eric J Feuer
Journal: J Natl Cancer Inst Date: 2002-07-03 Impact factor: 13.506

7. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening.

Authors: Sue Moss
Journal: Breast Cancer Res Date: 2005-08-25 Impact factor: 6.466

Are UK cancer cure rates worse than in most other European countries?

1. Cancer survival statistics should be viewed with caution.

2. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study.

3. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

4. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.

5. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe.

6. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

7. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening.

8. Completeness of cancer registration: a new method for routine use.

9. Recent trends in cancer mortality in the UK.

10. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.

Review 1. Interventions to reduce primary care delay in cancer referral: a systematic review.

2. The White Paper: a framework for survival?

3. Diagnosis: shifting the ROC curve.